Transamerica Financial Advisors’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$654 Buy
20
+14
+233% +$504 ﹤0.01% 1612
2026
Q1
$212 Buy
+6
New +$244 ﹤0.01% 1624
2025
Q4
Sell
-9
Closed -$423 1847
2025
Q3
$423 Buy
+9
New +$467 ﹤0.01% 1333

Other funds holding CNMD

Transamerica Financial Advisors's CNMD Position: Q2 2026 in Review

Transamerica Financial Advisors increased its CONMED (CNMD) stake by 233% in Q2 2026, buying an estimated $504 and bringing the position to 20 shares worth $654. The position accounts for ﹤0.01% of the portfolio, ranked #1612.

Transamerica Financial Advisors first reported a position in CNMD in Q3 2025 and has held it in 3 quarters since. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Transamerica Financial Advisors held 20 shares of CONMED worth $654 as of Q2 2026.
  • Transamerica Financial Advisors bought 14 CONMED shares in Q2 2026, an estimated $504.
  • CONMED made up ﹤0.01% of Transamerica Financial Advisors's portfolio in Q2 2026, its #1612 holding.
  • Transamerica Financial Advisors first reported a position in CONMED in Q3 2025 and has held it in 3 quarters since.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Transamerica Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.